ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
Diabetes and Microvascular Complications
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 225429" data-attributes="member: 13851"><p><u><strong>CLINICAL CARE POINTS</strong></u></p><p></p><p><strong><em>*Screening for diabetes-related microvascular complications should start immediately at the time of diagnosis of T2DM and within 5 years after the diagnosis of T1DM </em></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong><u>DSPN</u>:</strong></p><p><strong></strong></p><p><strong><em>*Screening for DSPN is essential as around 50% of individuals with DSPN are asymptomatic and will not volunteer symptoms </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*Before diagnosing DSPN, HCP may need to rule out other causes of neuropathy</em></strong></p><p><strong><em></em></strong></p><p><strong><em>*In clinical practice, nerve conduction studies and skin biopsy are rarely indicated </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*In individuals with DSPN, an annual foot examination may not be adequate and an exam/ inspection at every visit is suggested </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*Patients should be encouraged to check their feet daily </em></strong></p><p><strong><em></em></strong></p><p><strong><em>*Foot care education should be provided to the patient at least at the initial visit and as indicated </em></strong></p><p><strong><em></em></strong></p><p><em><strong>*In individuals who are at high risk for ulceration and amputations, HCP should prescribe diabetic shoes and consider a podiatry referral</strong></em></p><p></p><p></p><p></p><p><strong><u>DKD</u>:</strong></p><p></p><p><em><strong>*In individuals without DKD, annual serum creatinine and UACR are required </strong></em></p><p><em><strong></strong></em></p><p><em><strong>*An abnormal UACR requires 2 to 3 abnormal specimens within a 3- to 6-month period to confirm the diagnosis of albuminuria </strong></em></p><p><em><strong></strong></em></p><p><em><strong>*If the GFR is < 30 mL/min/1.73 m2, there is a rapid worsening of renal functions, or the etiology is unclear, the patient should be referred to nephrology </strong></em></p><p><em><strong></strong></em></p><p><em><strong>*The reliability of hemoglobin A1c is low in advanced DKD </strong></em></p><p><em><strong></strong></em></p><p><strong><em>*In individuals with DKD, RAS blockade agent and/or SGLT-2i are recommended. Finerenone can reduce CKD progression and cardiovascular events</em></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong><u>DR</u>:</strong></p><p></p><p><em><strong>*An eye examination by an expert is needed at least annually for the first 2 years </strong></em></p><p><em><strong></strong></em></p><p><em><strong>*Individuals with diagnosed DR may require a more frequent monitoring schedule </strong></em></p><p><em><strong></strong></em></p><p><em><strong>*Digital retinal photography with remote reading may be an option in locations with limited access to ophthalmologic evaluation </strong></em></p><p><em><strong></strong></em></p><p><em><strong>*In patients seeking pregnancy, a comprehensive eye examination within 1 year before conception and then during pregnancy is indicated as pregnancy may exacerbate DR </strong></em></p><p><em><strong></strong></em></p><p><strong><em>*The use of RAS inhibitor has shown to reduce the incidence and risk of progression of DR</em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 225429, member: 13851"] [U][B]CLINICAL CARE POINTS[/B][/U] [B][I]*Screening for diabetes-related microvascular complications should start immediately at the time of diagnosis of T2DM and within 5 years after the diagnosis of T1DM [/I] [U]DSPN[/U]: [I]*Screening for DSPN is essential as around 50% of individuals with DSPN are asymptomatic and will not volunteer symptoms *Before diagnosing DSPN, HCP may need to rule out other causes of neuropathy *In clinical practice, nerve conduction studies and skin biopsy are rarely indicated *In individuals with DSPN, an annual foot examination may not be adequate and an exam/ inspection at every visit is suggested *Patients should be encouraged to check their feet daily *Foot care education should be provided to the patient at least at the initial visit and as indicated [/I][/B] [I][B]*In individuals who are at high risk for ulceration and amputations, HCP should prescribe diabetic shoes and consider a podiatry referral[/B][/I] [B][U]DKD[/U]:[/B] [I][B]*In individuals without DKD, annual serum creatinine and UACR are required *An abnormal UACR requires 2 to 3 abnormal specimens within a 3- to 6-month period to confirm the diagnosis of albuminuria *If the GFR is < 30 mL/min/1.73 m2, there is a rapid worsening of renal functions, or the etiology is unclear, the patient should be referred to nephrology *The reliability of hemoglobin A1c is low in advanced DKD [/B][/I] [B][I]*In individuals with DKD, RAS blockade agent and/or SGLT-2i are recommended. Finerenone can reduce CKD progression and cardiovascular events[/I] [U]DR[/U]:[/B] [I][B]*An eye examination by an expert is needed at least annually for the first 2 years *Individuals with diagnosed DR may require a more frequent monitoring schedule *Digital retinal photography with remote reading may be an option in locations with limited access to ophthalmologic evaluation *In patients seeking pregnancy, a comprehensive eye examination within 1 year before conception and then during pregnancy is indicated as pregnancy may exacerbate DR [/B][/I] [B][I]*The use of RAS inhibitor has shown to reduce the incidence and risk of progression of DR[/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
Diabetes and Microvascular Complications
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top